Hydrochlorothiazide-13C,D2

SZ CAT No:	SZ-H006D09
CAS No	1190006-03-1
Mol.F.	C613CH6D2ClN3O4S2
Mol.Wt.	300.7
Inv. Status	Custom Synthesis

Disclaimer

SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.

SynZeal will update these details as per new development or finding in product specification without further noticed.

Chemical Name: 6-Chloro-3,4-dihydro-2H-benzo[e][1,2,4]thiadiazine-7-sulfonamide-3-13C-3,3-d2 1,1-dioxide

Shipping Temperature: Ambient

HSN Code: 38229010

Country of Origin: India

Smiles: ClC1=CC(N[13C]([2H])([2H])NS2(=O)=O)=C2C=C1S(=O)(N)=O

Purification and identification of an impurity in bulk hydrochlorothiazide
xueguang fang,1 richard todd bibart,1 suzanne mayr,1 winnie yin,1 paul a. harmon,2 jennifer finnegan mccafferty,3 r. jeffrey tyrrell,4 robert a. reed
journal of pharmaceutical sciences, vol. 90, no. 11, november 2001

Simultaneous Determination of Hydrochlorothiazide and Benazepril Hydrochloride or Amiloride Hydrochloride in Presence of Hydrochlorothiazide Impurities: Chlorothiazide and Salamide by HPTLC Method
Ibrahim A. Naguib1, Eglal A. Abdelaleem1, Hala E. Zaazaa2 and Mohammed E. Draz
Journal of Chromatographic Science 2014;1–6

A Validated High-Performance Thin-Layer Chromatographic Method for the Simultaneous Determination of Zofenopril Calcium and Hydrochlorothiazide in the Presence of the Hydrochlorothiazide Impurities: Chlorothiazide and Salamide
Mamdouh R Rezk, Ahmed S Fayed, Hoda M Marzouk, Samah S Abbas
Journal of AOAC International, Volume 101, Issue 4, 1 July 2018, Pages 1031–1041

An improved validated HPLC method for separation of metoprolol and hydrochlorothiazide impurities in metoprolol and hydrochlorothiazide tablets
Avinash S. Patil1 , Shakil S. Sait2 , Abhijit Deshamukh1 and Girish Deshpande1
Der Pharmacia Lettre, 2015, 7 (2):183-190

Method Development and Validation for the Determination of Potential Impurities Present in Olmesartan Medoxomil and Hydrochlorothiazide in Fixed Dose Combination Drug Product by Using Reverse Phase – Ultra-Performance Liquid Chromatography Coupled with Diode-Array Detector
R. srikanth reddy,1 r. murali krishna,2 n. a. vekaria,1 sumathi v. rao,1 and bhaskara p. v. mantena1
Journal of Liquid Chromatography & Related Technologies, 38: 1343–1354, 2015

Hydrochlorothiazide-13C,D2 is chemically 6-Chloro-3,4-dihydro-2H-benzo[e][1,2,4]thiadiazine-7-sulfonamide-3-13C-3,3-d2 1,1-dioxide. Hydrochlorothiazide-13C,D2 is supplied with detailed characterization data compliant with regulatory guideline. Hydrochlorothiazide-13C,D2 can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Hydrochlorothiazide.

The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.

Hydrochlorothiazide-13C,D2

Contacts

Our Locations